Editorial
World J Hepatol
12(1):1-5.
Published online Jan 27, 2020.
doi: 10.4254/wjh.v12.i1.1
Abstract (877)
|
Core Tip (546)
|
Full Article (HTML) (2110)
|
Figures (1-1) (224)
|
Full Article (PDF)-1292K (521)
|
Audio-487K (10)
|
Peer-Review Report-241K (134)
|
Answering Reviewers-146K (141)
|
Received: 12/10/2019
|
Revised: 12/17/2019
|
Accepted: 12/20/2019
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (7312)
|
Similar Articles (2)
|
Timeline of Article Publication (2)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
World J Hepatol
12(1):6-9.
Published online Jan 27, 2020.
doi: 10.4254/wjh.v12.i1.6
Abstract (589)
|
Core Tip (525)
|
Full Article (HTML) (3088)
|
Figures (1-1) (256)
|
Tables (1-1) (198)
|
Full Article (PDF)-957K (291)
|
Audio-216K (14)
|
Peer-Review Report-211K (141)
|
Answering Reviewers-127K (145)
|
Received: 09/01/2019
|
Revised: 11/21/2019
|
Accepted: 12/01/2019
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (8266)
|
Similar Articles (458)
|
Timeline of Article Publication (0)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
Lessons from “real life experience” of rifaximin use in the management of recurrent hepatic encephalopathy
World J Hepatol
12(1):10-20.
Published online Jan 27, 2020.
doi: 10.4254/wjh.v12.i1.10
Abstract (562)
|
Core Tip (532)
|
Article Highlights (659)
|
Full Article (HTML) (3145)
|
Figures (1-3) (239)
|
Tables (1-2) (228)
|
Full Article (PDF)-1190K (366)
|
Audio-823K (19)
|
Peer-Review Report-207K (139)
|
Answering Reviewers-150K (182)
|
Received: 06/30/2019
|
Revised: 09/30/2019
|
Accepted: 12/09/2019
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (9635)
|
Similar Articles (66)
|
Timeline of Article Publication (1)
|
Authors Evaluation (8)
|
Article Quality Tracking (2)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Imaging response predictors following drug eluting beads chemoembolization in the neoadjuvant liver transplant treatment of hepatocellular carcinoma
World J Hepatol
12(1):21-33.
Published online Jan 27, 2020.
doi: 10.4254/wjh.v12.i1.21
Abstract (582)
|
Core Tip (542)
|
Article Highlights (574)
|
Full Article (HTML) (3034)
|
Figures (1-6) (173)
|
Tables (1-7) (225)
|
Full Article (PDF)-2092K (396)
|
Audio-1556K (18)
|
Peer-Review Report-230K (137)
|
Answering Reviewers-141K (120)
|
Received: 07/05/2019
|
Revised: 10/02/2019
|
Accepted: 12/09/2019
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (7)
|
Total Visits (9647)
|
Similar Articles (1541)
|
Timeline of Article Publication (2)
|
Authors Evaluation (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open